 | • レポートコード：TPM-B04239 • 出版社/出版日：Transparency Market Research / 2018年3月 • レポート形態：英文、PDF、175ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、単球活性化試験の世界市場について調べ、単球活性化試験の世界規模、市場動向、市場環境、製品別分析、ソース別分析、用途別分析、産業別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・単球活性化試験の世界市場動向 ・単球活性化試験の世界市場環境 ・単球活性化試験の世界市場規模 ・単球活性化試験の世界市場規模：製品別 ・単球活性化試験の世界市場規模：ソース別 ・単球活性化試験の世界市場規模：用途別 ・単球活性化試験の世界市場規模：産業別 ・単球活性化試験の世界市場：地域別市場規模・分析 ・単球活性化試験の北米市場規模・予測 ・単球活性化試験のアメリカ市場規模・予測 ・単球活性化試験の中南米市場規模・予測 ・単球活性化試験のヨーロッパ市場規模・予測 ・単球活性化試験のアジア市場規模・予測 ・単球活性化試験の日本市場規模・予測 ・単球活性化試験の中国市場規模・予測 ・単球活性化試験のインド市場規模・予測 ・単球活性化試験の中東市場規模・予測 ・単球活性化試験のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global Monocyte Activation Tests Market: Overview
This report on monocyte activation tests studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various monocyte activation test products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered within the scope of the study. This section also provides the overall information and data analysis of the global monocyte activation tests market with respect to the leading market segments based on major products, major source, significant applications, key end-users, and geographies.
The monocyte activation tests market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product, source, application, end-user, and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global monocyte activation tests market.
Global Monocyte Activation Tests Market: Key Segments
Based on product, the market has been segmented into monocyte activation test kits and reagents. Rising preference for animal-free detection of pyrogens has increased the demand for monocyte activation tests kits and reagents. The market size and forecast for each of these sub-segment have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.
Based on source, the market has been segmented into blood based, peripheral blood mononuclear cell (PBMC) based and cell line based. Factors such as lack of animal usage, reliability, and accuracy are expected to support the growth of the blood-based segment during the forecast period. The market size and forecast for each of these sub-segment have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year
Based on application, the market has been segmented into lipid parenteral, dialysis liquids, toxic/immune-modulatory drugs, blood products and medical devices. Various medical devices are launched in the market every year and before the launch, every device needs to undergo pyrogen testing. This factor is responsible for the continuing dominance of the sub-segment. The market size and forecast for each of these sub-segment have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.
Based on end-user, the market has been classified into pharmaceuticals industry, biotechnology industry, medical devices industry and others. Discovery and launch of new products fuel the growth of the pharmaceuticals and biotechnology industry segments, which in turn is projected to boost the growth of the monocyte activation tests market during the forecast period. The market size and forecast for each of these sub-segment have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.
Global Monocyte Activation Tests Market: Regional Outlook
Geographically, the global monocyte activation tests market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries, Israel and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.
Companies Mentioned in Report
The report also profiles major players in the global monocyte activation tests market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The major players in this market are – Merck KGaA, Thermo Fisher Scientific, Charles River Laboratories International, Inc., Sanquin, Microcoat Biotechnologie GmbH, Becton, Dickinson and Company, SOLVIAS AG, and Lonza Group.
The global monocyte activation tests market is segmented as given below:
Global Monocyte Activation Tests Market Revenue, by Product, 2015–2025
Monocyte Activation Test Kits
Reagents
Global Monocyte Activation Tests Market Revenue, by Source, 2015–2025
Blood Based
Peripheral Blood Mononuclear Bell (PBMC) Based
Cell line Based
Global Monocyte Activation Tests Market Revenue, by Application, 2015–2025
Lipid Parenteral
Dialysis Liquids
Toxic/immune-modulatory Drugs
Blood Products
Medical Devices
Global Monocyte Activation Tests Market, by End-user
Pharmaceuticals Industry
Biotechnology Industry
Medical Devices Industry
Others
Global Monocyte Activation Tests Market Revenue, By Geography, 2015–2025
North America
U.S.
Canada
Europe
Germany
U.K.
Italy
France
Spain
Rest of Europe
Asia Pacific (Except Japan)
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC countries
South Africa
Israel
Rest of Middle East & Africa
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Monocyte Activation Test Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Monocyte Activation Test Market Analysis and Forecasts, 2015–2025
4.5. Porter’s Five Forces Analysis
4.6. Advancement in Pyrogen Tests
4.7. Healthcare Industry Overview
4.8. Global Monocyte Activation Test (MAT): Turnaround Time
5. Global Monocyte Activation Test Market Analysis and Forecasts, By Product
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Market Value Forecast By Product, 2015–2025
5.3.1. Monocyte Activation Test Kits
5.3.2. Reagents
5.4. Market Attractiveness By Product
6. Global Monocyte Activation Test Market Analysis and Forecasts, By Source
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Source, 2015–2025
6.3.1. Blood Based
6.3.2. Peripheral Blood Mononuclear Cell (PBMC) Based
6.3.3. Cell Line Based
6.4. Market Attractiveness By Source
7. Global Monocyte Activation Test Market Analysis and Forecasts, By Application
7.1. Introduction and Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Application, 2015–2025
7.3.1. Lipid Parenteral
7.3.2. Dialysis Liquids
7.3.3. Toxic/immune-modulatory Drugs
7.3.4. Blood Products
7.3.5. Medical Devices
7.4. Market Attractiveness By Application
8. Global Monocyte Activation Test Market Analysis and Forecasts, By End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By End-user, 2015–2025
8.3.1. Pharmaceuticals Industry
8.3.2. Biotechnology Industry
8.3.3. Medical devices Industry
8.3.4. Others
8.4. Market Attractiveness By End-user
9. Global Monocyte Activation Test Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Share Analysis and Forecast (2015-2025), By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness by Region
10. North America Monocyte Activation Test Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Forecast By Product, 2015–2025
10.2.1. Monocyte Activation Test Kits
10.2.2. Reagents
10.3. Market Forecast By Source, 2015–2025
10.3.1. Blood Based
10.3.2. Peripheral Blood Mononuclear Cell (PBMC) Based
10.3.3. Cell Line Based
10.4. Market Forecast By Application, 2015–2025
10.4.1. Lipid Parenteral
10.4.2. Dialysis Liquids
10.4.3. Toxic/immune-modulatory Drugs
10.4.4. Blood Products
10.4.5. Medical Devices
10.5. Market Forecast By End-users, 2015–2025
10.5.1. Pharmaceuticals industry
10.5.2. Biotechnology industry
10.5.3. Medical devices industry
10.5.4. Others
10.6. Market Forecast By Country, 2015–2025
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product
10.7.2. By Source
10.7.3. By Application
10.7.4. By End-user
10.7.5. By Country
11. Europe Monocyte Activation Test Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Forecast By Product, 2015–2025
11.2.1. Monocyte Activation Test Kits
11.2.2. Reagents
11.3. Market Forecast By Source, 2015–2025
11.3.1. Blood Based
11.3.2. Peripheral Blood Mononuclear Cell (PBMC) Based
11.3.3. Cell Line Based
11.4. Market Forecast By Application, 2015–2025
11.4.1. Lipid parenteral
11.4.2. Dialysis liquids
11.4.3. Toxic/immune-modulatory drugs
11.4.4. Blood products
11.4.5. Medical devices
11.5. Market Forecast By End-users, 2015–2025
11.5.1. Pharmaceuticals industry
11.5.2. Biotechnology industry
11.5.3. Medical devices industry
11.5.4. Others
11.6. Market Forecast By Country, 2015–2025
11.6.1. Germany
11.6.2. France
11.6.3. U.K.
11.6.4. Spain
11.6.5. Italy
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Source
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Asia Pacific Monocyte Activation Test Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Forecast By Product, 2015–2025
12.2.1. Monocyte Activation Test Kits
12.2.2. Reagents
12.3. Market Forecast By Source, 2015–2025
12.3.1. Blood Based
12.3.2. Peripheral Blood Mononuclear Cell (PBMC) Based
12.3.3. Cell Line Based
12.4. Market Forecast By Application, 2015–2025
12.4.1. Lipid parenteral
12.4.2. Dialysis liquids
12.4.3. Toxic/immune-modulatory drugs
12.4.4. Blood products
12.4.5. Medical devices
12.5. Market Forecast By End-users, 2015–2025
12.5.1. Pharmaceuticals industry
12.5.2. Biotechnology industry
12.5.3. Medical devices industry
12.5.4. Others
12.6. Market Forecast By Country, 2015–2025
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Source
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country
13. Latin America Monocyte Activation Test Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Forecast By Product, 2015–2025
13.2.1. Monocyte Activation Test Kits
13.2.2. Reagents
13.3. Market Forecast By Source, 2015–2025
13.3.1. Blood Based
13.3.2. Peripheral Blood Mononuclear Cell (PBMC) Based
13.3.3. Cell Line Based
13.4. Market Forecast By Application, 2015–2025
13.4.1. Lipid parenteral
13.4.2. Dialysis liquids
13.4.3. Toxic/immune-modulatory drugs
13.4.4. Blood products
13.4.5. Medical devices
13.5. Market Forecast By End-users, 2015–2025
13.5.1. Pharmaceuticals industry
13.5.2. Biotechnology industry
13.5.3. Medical devices industry
13.5.4. Others
13.6. Market Forecast By Country, 2015–2025
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Source
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country
14. Middle East & Africa Monocyte Activation Test Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Forecast By Product, 2015–2025
14.2.1. Monocyte Activation Test Kits
14.2.2. Reagents
14.3. Market Forecast By Source, 2015–2025
14.3.1. Blood Based
14.3.2. Peripheral Blood Mononuclear Cell (PBMC) Based
14.3.3. Cell Line Based
14.4. Market Forecast By Application, 2015–2025
14.4.1. Lipid parenteral
14.4.2. Dialysis liquids
14.4.3. Toxic/immune-modulatory drugs
14.4.4. Blood products
14.4.5. Medical devices
14.5. Market Forecast By End-users, 2015–2025
14.5.1. Pharmaceuticals industry
14.5.2. Biotechnology industry
14.5.3. Medical devices industry
14.5.4. Others
14.6. Market Forecast By Country, 2015–2025
14.6.1. South Africa
14.6.2. Israel
14.6.3. GCC
14.6.4. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Source
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country
15. Competition Landscape
15.1. Key Players & Their Competitive Positioning (2016)
15.2. Market Player – Competition Matrix (By Tier and Size of companies)
15.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
15.3.1. Merck KGaA
15.3.1.1. Overview (HQ, Employee Strength, Business Segments)
15.3.1.2. Financials
15.3.1.3. Recent Developments
15.3.1.4. SWOT Analysis
15.3.1.5. Strategy
15.3.2. Thermo Fisher Scientific
15.3.2.1. Overview (HQ, Employee Strength, Business Segments)
15.3.2.2. Financials
15.3.2.3. Recent Developments
15.3.2.4. SWOT Analysis
15.3.2.5. Strategy
15.3.3. Charles River Laboratories International, Inc.
15.3.3.1. Overview (HQ, Employee Strength, Business Segments)
15.3.3.2. Financials
15.3.3.3. Recent Developments
15.3.3.4. SWOT Analysis
15.3.3.5. Strategy
15.3.4. Sanquin
15.3.4.1. Overview (HQ, Employee Strength, Business Segments)
15.3.4.2. Financials
15.3.4.3. Recent Developments
15.3.4.4. SWOT Analysis
15.3.4.5. Strategy
15.3.5. Microcoat Biotechnologie GmbH
15.3.5.1. Overview (HQ, Employee Strength, Business Segments)
15.3.5.2. Recent Developments
15.3.5.3. SWOT Analysis
15.3.5.4. Strategy
15.3.6. Becton, Dickinson and Company
15.3.6.1. Overview (HQ, Employee Strength, Business Segments)
15.3.6.2. Financials
15.3.6.3. Recent Developments
15.3.6.4. SWOT Analysis
15.3.6.5. Strategy
15.3.7. SOLVIAS AG
15.3.7.1. Overview (HQ, Employee Strength, Business Segments)
15.3.7.2. Financials
15.3.7.3. Recent Developments
15.3.7.4. SWOT Analysis
15.3.7.5. Strategy
15.3.8. Lonza Group
15.3.8.1. Overview (HQ, Employee Strength, Business Segments)
15.3.8.2. Financials
15.3.8.3. Recent Developments
15.3.8.4. SWOT Analysis
15.3.8.5. Strategy
Table 01: Global Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Product, 2015–2025
Table 02: Global Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Source, 2015–2025
Table 03: Global Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Application, 2015–2025
Table 04: Global Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by End-user, 2015–2025
Table 05: Global Monocyte Activation Tests Market Size (US$ Thousand) Forecast, by Region, 2015–2025
Table 06: North America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Country, 2015–2025
Table 07: North America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Product, 2015–2025
Table 08: North America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Source, 2015–2025
Table 09: North America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Application, 2015–2025
Table 10: North America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by End-user, 2015–2025
Table 11: Europe Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Country/Sub-region, 2015–2025
Table 12: Europe Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Product, 2015–2025
Table 13: Europe Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Source, 2015–2025
Table 14: Europe Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Application, 2015–2025
Table 15: Europe Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by End-user, 2015–2025
Table 16: Asia Pacific Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Country/Sub-region, 2015–2025
Table 17: Asia Pacific Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Product, 2015–2025
Table 18: Asia Pacific Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Source, 2015–2025
Table 19: Asia Pacific Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Application, 2015–2025
Table 20: Asia Pacific Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by End-user, 2015–2025
Table 21: Latin America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Country/Sub-region, 2015–2025
Table 22: Latin America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Product, 2015–2025
Table 23: Latin America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Source, 2015–2025
Table 24: Latin America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Application, 2015–2025
Table 25: Latin America Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by End-user, 2015–2025
Table 26: Middle East & Africa Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Country/Sub-region, 2015–2025
Table 27: Middle East & Africa Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Product, 2015–2025
Table 28: Middle East & Africa Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Source, 2015–2025
Table 29: Middle East & Africa Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by Application, 2015–2025
Table 30: Middle East & Africa Monocyte Activation Tests Market Value (US$ Thousand) Forecast, by End-user, 2015–2025